Loading…
Loading grant details…
| Funder | British Heart Foundation |
|---|---|
| Recipient Organization | University of Glasgow |
| Country | United Kingdom |
| Start Date | Feb 01, 2021 |
| End Date | Jan 31, 2024 |
| Duration | 1,094 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | PG/19/28/34310 |
Background: More than 247,000 coronary angiograms are performed in the NHS annually, and >1 in 3 patients have no evidence of obstructive coronary artery disease (NOCAD). The diagnosis and onward management may be uncertain and prognosis is affected. Hypothesis: Microvascular angina is common in patients with NOCAD and a CMR-strategy improves outcomes.
Design: A diagnostic imaging study and nested, randomised, controlled, strategy trial.
Inclusion: Consecutive patients (n=280; intention-to-treat) with angina and NOCAD (0.80) after invasive coronary angiography (ICA) will be invited to undergo cardiac magnetic resonance (CMR) with stress perfusion; 1:1 randomisation (CMR-disclosed/guided vs. CMR-blinded. Exclusions: 1) Alternative causes of angina (e.g. aortic stenosis, cardiomyopathy), 2) Contraindications to CMR.
Outcomes: Primary: Reclassification of the initial diagnosis after CMR. Secondary: Health status/quality-of-life; NHS resources. Blinded follow-up: minimum 6-months (last patient-in), maximum 24 months (first patient-in). Value: Results relevant to patients, clinicians and the NHS.
University of Glasgow
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant